Sign in

CIK 0001651308

  • Large accelerated filer

BeOne Medicines Ltd.

Sign in to watch
Ticker
BEIGF
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
981209416
Phone
+41 616851900
Business address
C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
Former names
BeiGene, Ltd.

Securities

  • ONC American Depositary Shares Nasdaq
  • BEIGF Common stock OTC
  1. 4 Open-market sale Chief Executive Officer sold 39,732 shares at an average $185.90 ($7,385,983)
  2. 4 Open-market sale Director sold 11,000 shares at an average $184.09 ($2,024,971)
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Grant or award CMO, Hematology acquired 48,438 shares (grant or award)
  12. 4 Grant or award CFO & Chief Strategy Officer acquired 55,887 shares (grant or award)
  13. 4 Grant or award President & GM China acquired 134,147 shares (grant or award)
  14. 4 Derivatives Options or other derivatives
  15. 4 Open-market sale Chief Executive Officer sold 900 shares at $175.07 ($157,563)
  16. 4 Open-market sale CFO & Chief Strategy Officer sold 453 shares at $170.84 ($77,391)
  17. 4 Open-market sale President & GM China sold 2,800 shares at an average $170.83 ($478,317)
  18. 4 Open-market sale CMO, Hematology sold 631 shares at $170.84 ($107,800)
  19. 4 Open-market sale Director sold 6,000 shares at an average $170.91 ($1,025,455)
  20. 4 Open-market sale CMO, Hematology sold 1,500 shares at an average $163.86 ($245,784)

Page 20 of 29 · 580 filings